These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7599355)

  • 21. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
    Floege J; Eng E; Young BA; Couser WG; Johnson RJ
    Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasodilator agents modulate rat glomerular mesangial cell growth and collagen synthesis.
    Tsai TJ; Lin RH; Chang CC; Chen YM; Chen CF; Ko FN; Teng CM
    Nephron; 1995; 70(1):91-9. PubMed ID: 7617123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of nodular sclerosis by insulin in rat mesangial cells in vitro: studies of collagen.
    Abrass CK; Spicer D; Raugi GJ
    Kidney Int; 1995 Jan; 47(1):25-37. PubMed ID: 7731154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular mesangial cell altered contractility in high glucose is Ca2+ independent.
    Hurst RD; Stevanovic ZS; Munk S; Derylo B; Zhou X; Meer J; Silverberg M; Whiteside CI
    Diabetes; 1995 Jul; 44(7):759-66. PubMed ID: 7789643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of heparin and type-IV collagen on IL-6 synthesis by rat glomerular mesangial cells.
    Benador NM; Girardin EP
    Nephron; 1997; 77(2):219-24. PubMed ID: 9346390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interaction of cells and the extracellular matrix in the mesangium].
    Mitrović S; Mitrović D; Marković-Lipkovski J
    Srp Arh Celok Lek; 2000; 128(1-2):34-41. PubMed ID: 10916462
    [No Abstract]   [Full Text] [Related]  

  • 27. Beneficial effects of C-peptide on renal morphology in diabetic rats.
    Sun W; Gao X; Zhao X; Cui D; Xia Q
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sirolimus on human mesangial cells.
    Esposito C; Valentino R; Villa L; Serpieri N; Mangione F; Grosjean F; Esposito V; Castoldi F; Sileno G; Montagna F; Maggi N; Torreggiani M; Marchi G; Dal Canton A
    Transplant Proc; 2010 May; 42(4):1344-6. PubMed ID: 20534297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin inhibits mesangial cell proliferation in habu-venom-induced glomerular injury.
    Coffey AK; Karnovsky MJ
    Am J Pathol; 1985 Aug; 120(2):248-55. PubMed ID: 3875292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S; Nakamura T
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparinlike glycosaminoglycans.
    Person JM; Lovett DH; Raugi GJ
    Am J Pathol; 1988 Dec; 133(3):609-14. PubMed ID: 3202119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glomerular extracellular matrices in rat diabetic glomerulopathy by scanning electron microscopy.
    Makino H; Yamasaki Y; Hironaka K; Ota Z
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):19-24. PubMed ID: 1352071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitory effect of heparin on glomerular mesangial cell].
    Zhang M; Guo M; Jin H
    Zhonghua Yi Xue Za Zhi; 1995 May; 75(5):273-5, 319. PubMed ID: 7656159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of glucose on matrix metalloproteinase activity in mesangial cells.
    McLennan SV; Yue DK; Turtle JR
    Nephron; 1998; 79(3):293-8. PubMed ID: 9678429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
    Nicholas SB; Aguiniga E; Ren Y; Kim J; Wong J; Govindarajan N; Noda M; Wang W; Kawano Y; Collins A; Hsueh WA
    Kidney Int; 2005 Apr; 67(4):1297-307. PubMed ID: 15780082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 9HODE stimulates cell proliferation and extracellular matrix synthesis in human mesangial cells via PPARgamma.
    Negishi M; Shimizu H; Okada S; Kuwabara A; Okajima F; Mori M
    Exp Biol Med (Maywood); 2004 Nov; 229(10):1053-60. PubMed ID: 15522842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.
    McLennan SV; Martell SK; Yue DK
    Diabetes; 2002 Aug; 51(8):2612-8. PubMed ID: 12145178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesangial cell behavior in a three-dimensional extracellular matrix.
    Kitamura M; Mitarai T; Maruyama N; Nagasawa R; Yoshida H; Sakai O
    Kidney Int; 1991 Oct; 40(4):653-61. PubMed ID: 1745014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells.
    Mishra R; Emancipator SN; Kern T; Simonson MS
    Kidney Int; 2005 Jan; 67(1):82-93. PubMed ID: 15610231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.